Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and Cefuroxime Prophylaxis for Post-Hysterectomy Infections
NCT05337566Recruiting
- Sponsor
- Helsinki University Hospital
- Start
- Sep 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Infection comparing Azithromycin + Cefuroxime with Placebo + Cefuroxime (2 arms). Primary endpoint: Number of post-hysterectomy episodes with deep infections at 30 days. Started Sep 2022; status: recruiting.
02
Drugs
azithromycin
03
Conditions
Infection
Beyond the preview
Go deeper on NCT05337566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05337566.